World's Best Scientists 2026 revealed!
Experimental and Molecular Pathology
H-index 19

Experimental and Molecular Pathology

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 2693 30 27 8

Additional Metrics

Number of Best Scientists*: 99
Documents by Best Scientists*: 107
Top 100 Ranked Scientists*: 2
SCIMAGO H-index: 81
SCIMAGO SJR: 0.803
Impact Factor: 3.7

Overview

Top Research Topics at Experimental and Molecular Pathology?

Experimental and Molecular Pathology tackles a plethora of topics, such as Internal medicine, Pathology, Endocrinology, Biochemistry and Cancer research. Issues in Internal medicine were discussed, taking into consideration concepts from other disciplines like Immunology, Oncology and Cardiology. More specifically, the research on Immunology in it is related to Inflammation.

The studies in Pathology featured incorporate elements of Lung and Anatomy. Biochemistry and Molecular biology are closely related fields of research discussed in the journal. The Molecular biology study tackled is a key component of adjacent topics in the area of Cell culture.

The concepts on Cancer research presented in it can also apply to other research fields, including Carcinogenesis, Cancer, Cell growth, Apoptosis and microRNA.

  • Internal medicine (29.72%)
  • Pathology (28.39%)
  • Endocrinology (24.76%)

What are the most cited papers published in the journal?

  • Nanoparticle-based targeted drug delivery (1589 citations)
  • Discovery and Development of the G-rich Oligonucleotide AS1411 as a Novel Treatment for Cancer (568 citations)
  • Transformation of alveolar type 2 cells to type 1 cells following exposure to NO2. (509 citations)

Research areas of the most cited articles at Experimental and Molecular Pathology:

The published papers mainly deal with areas of study such as Pathology, Internal medicine, Endocrinology, Biochemistry and Immunology. The journal articles hold forums on Pathology that merge themes from other disciplines such as Cancer, Cancer research and Endothelium. Aside from discussions in Biochemistry, the most cited articles also deal with the subject of Molecular biology which intersects with Cell culture disciplines.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Gene
  • Enzyme

The previous edition focused in particular on these issues:

The scientific interests tackled in Experimental and Molecular Pathology are Cancer research, Internal medicine, microRNA, Apoptosis and Downregulation and upregulation. While Experimental and Molecular Pathology focused on Cancer research, it was also able to explore topics like Cancer, Colorectal cancer, Metastasis, Cell growth and Biomarker (medicine). In the journal, Gastroenterology, Endocrinology, Oncology and Genotype are investigated in conjunction with one another to address concerns in Internal medicine research.

The majority of Endocrinology studies presented zero in on Diabetes mellitus. It holds forums on Apoptosis that merges themes from other disciplines such as Cell, Blot, Molecular biology, Flow cytometry and Gene silencing. The Molecular biology works featured in the journal incorporate elements from Proinflammatory cytokine and Cell culture.

The most cited articles from the last journal are:

  • Therapeutic potential of mesenchymal stem cell-derived extracellular vesicles as novel cell-free therapy for treatment of autoimmune disorders. (7 citations)
  • LncRNAs and miRNAs participate in determination of sensitivity of cancer cells to cisplatin. (4 citations)
  • The effect of LncRNA SNHG16 on vascular smooth muscle cells in CHD by targeting miRNA-218-5p. (4 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Experimental and Molecular Pathology (based on the number of publications) are:

  • Samuel W. French (148 papers) absent at the last edition,
  • Wilbur A. Thomas (55 papers) absent at the last edition,
  • Jun Li (53 papers) absent at the last edition,
  • Barbara A. French (51 papers) absent at the last edition,
  • Kyu Taik Lee (50 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Experimental and Molecular Pathology (based on the number of publications) are:

  • Albany Medical College (154 papers) absent at the last edition,
  • UCLA Medical Center (140 papers) absent at the last edition,
  • Wake Forest University (56 papers) published 1 paper at the last edition,
  • National Institutes of Health (56 papers) absent at the last edition,
  • University of Toronto (55 papers) absent at the last edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 16.50% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 1.16% were posted by at least one author from the top 10 institutions publishing in the journal. Another 2.33% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 20.93% of all publications and 75.58% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Practical Applications and Impact on Nursing

This journal not only adds to the existing pool of knowledge in experimental and molecular pathology but can also have practical applications in various fields such as nursing. Studying these research topics can enhance the understanding and skills of nurses, allowing them to provide better patient care. For instance, the in-depth knowledge acquired about cancer research, immunology, and endocrinology can equip nurses with a more comprehensive ability to deal with patients suffering from various types of cancers, immune disorders, and endocrine diseases. Moreover, this research can potentially promote the development of more effective treatments and medications, reducing patient suffering and mortality rates. Accordingly, advancements in these key research areas can contribute to the improvement of healthcare quality and patient outcomes. Therefore, nurses and nursing students should strive to keep up-to-date with the latest research to stay on the cutting edge of their profession and provide the best possible patient care. Online degree programs, such as the one provided by best online nursing programs in Wyoming, can be a great opportunity for aspiring nurses and those looking to deepen their understanding and further their skills in the field. By integrating knowledge from experimental and molecular pathology along with other disciplines, nurses can transcend traditional boundaries and advocate for their patients while delivering comprehensive care that meets their complex healthcare needs. In conclusion, the insights from experimental and molecular pathology can facilitate evidence-based nursing practices, healthcare innovation, as well as contribute to medical research and the well-being of patients.

Top Publications

  • Cytokeratin 7 and cytokeratin 20 expression in cancer: A tissue microarray study on 15,424 cancers.

    (2022)
    53 Citations
  • miR-200c increases the sensitivity of breast cancer cells to Doxorubicin through downregulating MDR1 gene.

    (2022)
    40 Citations
  • Dual role of heme iron in cancer; promotor of carcinogenesis and an inducer of tumour suppression.

    Sujani M.K. Gamage;Katherine T.W. Lee;D. Lakal O. Dissabandara;Alfred King-Yin Lam

    (2021)
    30 Citations
  • The cell theory and cellular pathology: Discovery, refinements and applications fundamental to advances in biology and medicine.

    L. Maximilian Buja

    (2021)
    22 Citations
  • CircWHSC1 regulates malignancy and glycolysis by the miR-212-5p/AKT3 pathway in triple-negative breast cancer

    (2021)
    18 Citations
  • Bile acids aggravate nonalcoholic steatohepatitis and cardiovascular disease in SHRSP5/Dmcr rat model

    Shusei Yamamoto;Ikumi Sato;Natsuki Fukuhama;Natsumi Akiyama

    (2020)
    10 Citations
  • The coding microsatellite mutation profile of PMS2-deficient colorectal cancer.

    Sanne W. Bajwa ten Broeke;Alexej Ballhausen;Aysel Ahadova;Manon Suerink

    (2021)
    10 Citations
  • Cytokeratin 20 expression is linked to stage progression and to poor prognosis in advanced (pT4) urothelial carcinoma of the bladder.

    (2023)
    8 Citations
  • ZNF677 downregulation by promoter hypermethylation as a driver event through gastric tumorigenesis.

    Negar Bidar;Tayebeh Rezaei;Mohammad Amini;Asiyeh Jebelli

    (2021)
    7 Citations
  • Nuclear and stromal expression of Manic fringe in renal cell carcinoma

    Wei Kang Cheng;Gurjeet Kaur;Elin Sjöberg;Magnus Frödin

    (2021)
    7 Citations

Related Online Degrees & Career Pathways

For students interested in healthcare careers beyond Medicine, online nursing programs provide flexible alternatives that can accelerate entry into the field. Many universities offer accelerated bsn programs for non nurses, designed to help those without a nursing background earn a Bachelor of Science in Nursing quickly and efficiently.

Once in nursing, advancing to specialized roles is a common goal. Becoming a nurse practitioner requires dedicated study, but understanding how many years to become a nurse practitioner can help candidates plan their education path effectively. Programs vary in length but typically balance comprehensive training with the practical need to enter the workforce.

For existing nurses aiming to boost their qualifications, enrolling in a 6-month rn to bsn program offers a rapid route to obtaining a bachelor's degree. These programs cater to working professionals by providing intensive coursework within a condensed timeframe.

Career prospects for advanced nursing roles are promising. For example, the dnp pmhnp salary data highlights the competitive compensation available for psychiatric nurse practitioners, reflecting the growing demand for mental health specialists in the healthcare system.

Best Scientists Contributing to This Journal

Recently Published Articles